I n only a few short months, the Society of Nuclear Medicine (SNM) will host its Mid-Winter Meeting—an exceptional educational program of scientific content in nuclear medicine, molecular imaging, and clinical trials. The meeting, which will be held January 26–29, 2012, at the Hilton Orlando (FL) at Walt Disney World, brings together leading nuclear and molecular imaging physicians, radiologists, cardiologists, laboratory professionals, pharmacists, scientists, and technologists representing the world’s top medical and academic institutions and centers. Recognizing the broad spectrum of skill sets among SNM’s members and their desire for the latest information, SNM has restructured its Mid-Winter Meeting for 2012. The improved meeting will provide all attendees with the benefits of 4 distinct content tracks—the SNM/SNM Technologist Section (SNMTS) Educational Symposium, the 2012 American College of Nuclear Medicine (ACNM) Annual Meeting, the SNM Center for Molecular Imaging Innovation and Translation (CMIIT) Summit on Dementia, and the SNM Clinical Trials Network Workshop. The ACNM Annual Meeting kicks off on Thursday, January 26, with a focus on strategies for improving the practice of nuclear medicine, with topics including infection imaging, lung cancer staging, 131I therapy, health care reform and its impact on medical imaging, and the value of correlative imaging with MR. An ACNM banquet and awards dinner will be held on Thursday following the sessions. Also taking place on Thursday is the CMIIT Summit on Dementia. The speakers at this summit will assess the state of the art in diagnostic evaluation of dementia and will highlight recent key developments and controversies in the clinical translation of radiopharmaceuticals for dementia imaging. In addition, a speaker from the patient advocacy community will provide an important and unique perspective on dementia. Two panel discussions during the session will allow for more indepth conversations and questions. Friday begins the 3-d SNM/SNMTS education program, which covers a wide variety of topics, including current clinical practice of positron emission tomography (PET) oncology, guidance on integrating PET imaging into therapeutic clinical trials, imaging of musculoskeletal disease, and translating molecular imaging into clinical practice, among others. SNM’s Correlative Imaging Council and ACNM will offer a review course on computed tomography with more than 100 cases. A new case review course on MR imaging will be hosted by SNM’s Correlative Imaging Council as well. SNM’s Clinical Trials Network will host its 1-d educational symposium on Friday, January 27. With the deadline for compliance with the Food and Drug Administration’s Good Manufacturing Practice requirements for PET drugs (21 CFR Part 212) on December 12, 2011, the meeting will provide an update on the process. It will also offer an in-depth look at clinical trial designs for nuclear and molecular imaging. The comprehensive program for the meeting is a result of the dedication of several key volunteers: Satoshi Minoshima, MD, PhD, associate chair of SNM’s Scientific Program Committee; Ronald Walker, MD, program chair of the ACNM meeting; and Ellie Zimmer, CNMT, RT(N), Mid-Winter Meeting chair, and Nancy McDonald DeLoatch, RT(R)(N), CNMT, NCT, Mid-Winter Meeting associate chair, of the Technologist Section. Their guidance has enabled SNM to once again present a meeting with valuable information for the nuclear and molecular imaging community. In addition to the outstanding education and scientific program, the SNM Mid-Winter Meeting also provides a great opportunity for networking with peers throughout the field. I encourage members of the nuclear and molecular imaging community to make plans to attend the MidWinter Meeting to take advantage of this one-of-a-kind event. More information about the meeting can be found at www.snm.org/mwm.